| Literature DB >> 34621324 |
Xue Hou1, Huajuan Zhang2, Yahong Nie3, Yun Zhang4, Jinhua Wang5, Hua Xu6.
Abstract
OBJECTIVE: To study the effects of psychological care combined with traditional Chinese medicine treatment on the postoperative psychological stress response and the expression levels of serum C-reactive protein (CRP) and interferon-γ (IFN-γ) in patients with advanced cervical cancer.Entities:
Year: 2021 PMID: 34621324 PMCID: PMC8492293 DOI: 10.1155/2021/5612925
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Comparison of general information between the two groups of patients.
| Indicator | Control group | Study group |
| |
|---|---|---|---|---|
| Case | 116 | 116 | ||
| Age (years) | 0.070 | 0.791 | ||
| >43 | 67 | 65 | ||
| ≤43 | 49 | 51 | ||
| Course of the disease (years) | 0.322 | 0.570 | ||
| <3 | 78 | 82 | ||
| 3-4 | 38 | 34 | ||
| Educational level | 0.078 | 0.780 | ||
| High school and below | 64 | 60 | ||
| Specialized degree and above | 52 | 56 | ||
| BMI | 0.088 | 0.957 | ||
| <18.5 | 17 | 16 | ||
| 18.5–24.9 | 84 | 86 | ||
| ≥25 | 15 | 14 | ||
| Clinical stage | 0.254 | 0.881 | ||
| IIIa | 47 | 48 | ||
| IIIb | 45 | 47 | ||
| IVa | 24 | 21 | ||
| Pathological type | 0.248 | 0.618 | ||
| Squamous cell carcinoma | 92 | 95 | ||
| Adenocarcinoma | 24 | 21 |
Comparison of clinical efficacy between two groups of patients (n (%)).
| Group |
| CR | PR | SD | PD | Total effective rate |
|---|---|---|---|---|---|---|
| Control group | 116 | 24 | 77 | 9 | 6 | 101 (87.07) |
| Study group | 116 | 13 | 62 | 28 | 13 | 75 (64.66) |
|
| 17.225 | |||||
| 0.001 |
Figure 1Comparison of VAS scores of the patients after treatment between the control group (n = 116) and the study group (n = 116). P < 0.05.
Comparison of SCL-90 scores before and after treatment in the two groups (‾x ± s).
| Group |
| Somatization | Interpersonal sensitivity | Anxiety | Phobia | Psychoticism | |
|---|---|---|---|---|---|---|---|
| Study group | Before treatment | 116 | 36.72 ± 3.45 | 39.16 ± 4.23 | 38.34 ± 4.71 | 35.96 ± 3.37 | 36.43 ± 4.52 |
| After treatment | 116 | 12.56 ± 2.13 | 11.48 ± 2.76 | 12.14 ± 3.48 | 10.87 ± 2.26 | 10.93 ± 2.17 | |
|
| 11.263 | 13.861 | 23.654 | 4.782 | 7.665 | ||
|
| <0.05 | <0.05 | <0.05 | <0.05 | <0.05 | ||
| Control group | Before treatment | 116 | 35.63 ± 3.36 | 39.87 ± 3.94 | 37.81 ± 5.27 | 35.57 ± 3.44 | 35.67 ± 4.31 |
| After treatment | 116 | 21.34 ± 2.71 | 22.51 ± 2.32 | 21.62 ± 4.47 | 19.26 ± 2.31 | 20.42 ± 3.32 | |
|
| 7.036 | 8.541 | 11.230 | 3.117 | 6.548 | ||
|
| <0.05 | <0.05 | <0.05 | <0.05 | <0.05 | ||
|
| Obsessive-compulsive symptoms | Depression | Hostility | Paranoia | Others | ||
| Study group | Before treatment | 116 | 35.76 ± 4.41 | 38.97 ± 4.68 | 36.62 ± 5.53 | 37.73 ± 4.54 | 38.24 ± 4.21 |
| After treatment | 116 | 11.05 ± 2.61 | 11.27 ± 2.46 | 10.92 ± 2.84 | 11.21 ± 2.53 | 12.57 ± 2.72 | |
|
| 15.423 | 8.662 | 11.346 | 12.951 | 7.652 | ||
|
| <0.05 | <0.05 | <0.05 | <0.05 | <0.05 | ||
| Control group | Before treatment | 116 | 35.78 ± 3.83 | 37.95 ± 5.19 | 36.15 ± 5.26 | 36.75 ± 5.66 | 38.87 ± 4.53 |
| After treatment | 116 | 21.53 ± 2.44 | 21.66 ± 3.23 | 20.41 ± 3.27 | 21.58 ± 3.68 | 20.54 ± 3.17 | |
|
| 8.932 | 6.231 | 7.145 | 10.213 | 6.430 | ||
|
| <0.05 | <0.05 | <0.05 | <0.05 | <0.05 | ||
Figure 2Comparison of serum CRP and IFN-γ expression levels before and after treatment between the control group (n = 116) and the study group (n = 116). (a) The comparison of serum CRP expression levels before and after treatment between the control group (n = 116) and the study group (n = 116). (b) The comparison of serum IFN-γ expression levels before and after treatment between the control group (n = 116) and the study group (n = 116). P < 0.05.
Comparison of quality of life scores between the two groups (‾x ± s).
| Group |
| Somatic function | Emotional function | Social function | Cognitive function | Character function |
|---|---|---|---|---|---|---|
| Study group | 116 | 91.24 ± 5.67 | 88.36 ± 5.24 | 89.64 ± 6.53 | 90.77 ± 6.15 | 87.23 ± 7.96 |
| Control group | 116 | 86.14 ± 4.78 | 72.45 ± 4.57 | 74.23 ± 5.74 | 88.66 ± 5.36 | 71.41 ± 6.28 |
|
| 0.352 | 7.452 | 6.781 | 0.730 | 4.512 | |
|
| >0.05 | <0.05 | <0.05 | >0.05 | <0.05 |
Figure 3Comparison of long-term outcomes between the control group (n = 116) and the study group (n = 116).